Abstract
Rasagiline is a monoamine oxidase B (MAO-B) inhibitor with neuroprotective effects, whose dependence on MAO-B inhibition remains unclear. Here, indane-to-azaindane rasagiline isosteres (rac-2a and rac-2b) were developed to investigate whether neuroprotection can be decoupled from MAO-B inhibition. Direct regioselective oxidation of 4-azaindane catalyzed by Mn(OAc)2/tBuOOH afforded the key 4-azaindan-1-one intermediate (6a). In paraquat-insulted dopaminergic differentiated SH-SY5Y cells, both analogs showed neuroprotection at 10 and 100 μM, with rac-2b outperforming rasagiline. The azaindane analogs displayed markedly reduced MAO-B inhibition and no time-dependent inhibition. These findings demonstrate that rasagiline neuroprotection can be dissociated from MAO-B inhibition, supporting azaindane bioisosterism for exploring MAO-independent neuroprotection.
Funding Information
  • Fundação para a Ciência e a Tecnologia (2020.02311.CEECIND/CP1596/CT0004)
  • Fundação para a Ciência e a Tecnologia (2022.01175.PTDC)
  • Fundação para a Ciência e a Tecnologia (2023.14440.PEX)
  • Fundação para a Ciência e a Tecnologia (2024.02245.BD)
  • Fundação para a Ciência e a Tecnologia (LA/P/0140/2020)
  • Fundação para a Ciência e a Tecnologia (SFRH/BD/147463/2019)
  • Fundação para a Ciência e a Tecnologia (UI/BD/154888/2023)
  • Fundação para a Ciência e a Tecnologia (UID/50006/2025)
  • Fundação para a Ciência e a Tecnologia (UIDB/04378/2020)
  • Fundação para a Ciência e a Tecnologia (UIDP/04378/2020)
  • The Slovenian Research and Innovation Agency (P1-0208)
  • European Regional Development Fund (COMPETE2030-FEDER-00881500)
  • Rede de Química e Tecnologia (REQUIMTE 2025-42)
  • Rede de Química e Tecnologia (REQUIMTE 2025-43)

This publication has 58 references indexed in Scilit: